Rheumatoid arthritis, a complex multifactorial disease: On the way toward individualized medicine

With the availability of the human genome sequence and those of related species like chimpanzee, mouse, and rat, data driven research for tackling the molecular grounds of rheumatoid arthritis (RA), a multifactorial polygenic disease, can be considered a realistic challenge to the scientific community. A comprehensive research strategy is presented enabling the integration of multiple research efforts on studying autoimmunity by so called systems biology approaches. An integrative scientific concept is discussed of how to unravel molecular mechanisms of complex diseases by making use of state‐of‐the‐art methodologies in functional and comparative genomics. A continuous interchange of data‐driven and hypothesis‐driven research is adjoined to determine the nature of rheumatic diseases with autoimmune background. Instead of studying single genes and proteins, RNA and protein microarray profiles are currently obtained in numerous research projects producing read‐outs termed gene signatures rather than DNA and/or protein markers. A comprehensive study of the RNA, protein, and metabolite regimes is undertaken that eventually will lead to a “holistic” view of how all respective molecules, pathways and cells themselves interact with each other. Some of the above mentioned research aspects have already been studied by the authors, hopefully leading to new diagnostics and therapeutics in the future. © 2003 Wiley Periodicals, Inc. Med Res Rev.

[1]  A. Kang,et al.  Autoimmunity to type II collagen an experimental model of arthritis , 1977, The Journal of experimental medicine.

[2]  M. Dallman,et al.  Immunisation against heterologous type II collagen induces arthritis in mice , 1980, Nature.

[3]  R. Wells,et al.  Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[5]  G. Burmester,et al.  Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity , 1998, Zeitschrift für Rheumatologie.

[6]  M. Bantscheff,et al.  Probing the Tertiary Structure of Multidomain Proteins by Limited Proteolysis and Mass Spectrometry , 1998 .

[7]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[8]  Kraan,et al.  The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA) , 1999, Clinical and experimental immunology.

[9]  Eric Mjolsness,et al.  From Coexpression to Coregulation: An Approach to Inferring Transcriptional Regulation among Gene Classes from Large-Scale Expression Data , 1999, NIPS.

[10]  A. Kavanaugh An overview of immunomodulatory intervention in rheumatoid arthritis. , 1999, Drugs of today.

[11]  S. Nakano,et al.  Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. , 1999, Clinical and experimental rheumatology.

[12]  Nello Cristianini,et al.  Support vector machine classification and validation of cancer tissue samples using microarray expression data , 2000, Bioinform..

[13]  N. Wulffraat,et al.  Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[14]  P. Petrow,et al.  Cathepsin B and its endogenous inhibitor cystatin C in rheumatoid arthritis synovium. , 2000, The Journal of rheumatology.

[15]  Masanori Arita,et al.  Metabolic reconstruction using shortest paths , 2000, Simul. Pract. Theory.

[16]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Schrader,et al.  Peptidomics technologies for human body fluids. , 2001, Trends in biotechnology.

[18]  Neal S. Holter,et al.  Dynamic modeling of gene expression data. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Schrader,et al.  Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. , 2012, Combinatorial chemistry & high throughput screening.

[20]  J. Kos,et al.  Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis. , 2001, Biochemical and biophysical research communications.

[21]  J. Reginster,et al.  WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis. , 2001, Rheumatology.

[22]  E. Purisima,et al.  Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities. , 2001, Biochemistry.

[23]  S. Bowman,et al.  How many patients are eligible for anti-TNF therapy in the UK? , 2001, Rheumatology.

[24]  U. Lehmann,et al.  Quantitative Analysis of Promoter Hypermethylation in Laser-Microdissected Archival Specimens , 2001, Laboratory Investigation.

[25]  Hans-Jürgen Thiesen,et al.  Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis , 2002, Electrophoresis.

[26]  E. Davidson,et al.  Modeling transcriptional regulatory networks. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[27]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[28]  S. Ibrahim,et al.  Gene-expression profile of collagen-induced arthritis. , 2002, Journal of autoimmunity.

[29]  Wei Pan,et al.  A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments , 2002, Bioinform..

[30]  A. Zwinderman,et al.  Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. , 2002, Arthritis and rheumatism.

[31]  L. Juliano,et al.  Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides. , 2002, The Biochemical journal.

[32]  J. Doyle,et al.  Reverse Engineering of Biological Complexity , 2002, Science.

[33]  J. Kekow,et al.  Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor β levels in rheumatoid arthritis , 2002, Annals of the rheumatic diseases.

[34]  Wei-Min Liu,et al.  Robust estimators for expression analysis , 2002, Bioinform..

[35]  Lawrence Steinman,et al.  Autoantibody profiling for the study and treatment of autoimmune disease , 2002, Arthritis research.

[36]  U. Lehmann,et al.  Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. , 2002, Cancer research.

[37]  J. Kekow,et al.  Diagnostik und Therapiemonitoring mit Methoden der molekularen Medizin , 2002, Zeitschrift für Rheumatologie.

[38]  I Petersen,et al.  Grading of chronic synovitis--a histopathological grading system for molecular and diagnostic pathology. , 2002, Pathology, research and practice.

[39]  Reinhard Guthke,et al.  Knowledge-based assessment of gene expression data from chemiluminescence detection. , 2002, Journal of biotechnology.

[40]  H. Schlüter,et al.  Detection of protease activities with the mass-spectrometry-assisted enzyme-screening (MES) system , 2003, Analytical and bioanalytical chemistry.

[41]  Yoav Benjamini,et al.  Identifying differentially expressed genes using false discovery rate controlling procedures , 2003, Bioinform..

[42]  P. Lorenz,et al.  High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis , 2003, Arthritis research & therapy.

[43]  M. Bantscheff,et al.  Proteome Analysis of Diseased Joints from Mice Suffering from Collagen-Induced Arthritis , 2003, Clinical chemistry and laboratory medicine.

[44]  Masanori Arita In silico atomic tracing by substrate-product relationships in Escherichia coli intermediary metabolism. , 2003, Genome research.

[45]  D. Brömme,et al.  Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L. , 2003, European journal of biochemistry.

[46]  David Ward,et al.  Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data , 2003, Bioinform..

[47]  P. Lorenz,et al.  From transcriptome to proteome: Differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies , 2003, Proteomics.

[48]  Ezio Bartocci,et al.  Expressionview: visualization of quantitative trait loci and gene-expression data in Ensembl , 2003, Genome Biology.

[49]  M. Glocker,et al.  Matrix‐assisted laser desorption/ionization‐ quadrupole ion trap‐time of flight mass spectrometry sequencing resolves structures of unidentified peptides obtained by in‐gel tryptic digestion of haptoglobin derivatives from human plasma proteomes , 2003, Proteomics.

[50]  J. Epplen,et al.  Complex genetic predisposition in adult and juvenile rheumatoid arthritis , 2004, BMC Genetics.

[51]  Doulaye Dembélé,et al.  Fuzzy C-means Method for Clustering Microarray Data , 2003, Bioinform..

[52]  P. Lipsky,et al.  New concepts in the treatment of rheumatoid arthritis. , 2003, Annual review of medicine.

[53]  Walter Schubert,et al.  Topological proteomics, toponomics, MELK-technology. , 2003, Advances in biochemical engineering/biotechnology.

[54]  L. Moreland,et al.  Upcoming biologic agents for the treatment of rheumatic diseases , 2003, Current opinion in rheumatology.

[55]  Seung-Heon Hong,et al.  Madimadi, Korean folk medicine, blocks TNF-α, IL-1β, and IL-8 production by activated human immune cells , 2004 .

[56]  M. Spillantini,et al.  Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation? , 2004, Rheumatology International.

[57]  Robert Gentleman,et al.  matchprobes: a Bioconductor package for the sequence-matching of microarray probe elements , 2004, Bioinform..

[58]  S. Ibrahim,et al.  4th meeting of the EU research network EUROME: From the identification of genes and cellular networks in murine models of arthritis to novel therapeutic intervention strategies in rheumatoid arthritis, London, UK, 9 March 2004 , 2004, Arthritis research & therapy.

[59]  H. Thiesen,et al.  Identification of new quantitative trait loci in mice with collagen-induced arthritis. , 2004, Arthritis and rheumatism.

[60]  O. Meyer,et al.  NADPH Oxidase Priming and p47phox Phosphorylation in Neutrophils from Synovial Fluid of Patients with Rheumatoid Arthritis and Spondylarthropathy , 2002, Inflammation.

[61]  L. Klareskog,et al.  Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial , 2004, The Lancet.

[62]  M. Glocker,et al.  Mass spectrometric protein structure characterization reveals cause of migration differences of haptoglobin α chains in two‐dimensional gel electrophoresis , 2004, Proteomics.

[63]  Lisa M. D'Souza,et al.  Genome sequence of the Brown Norway rat yields insights into mammalian evolution , 2004, Nature.

[64]  P. Miossec An update on the cytokine network in rheumatoid arthritis , 2004, Current opinion in rheumatology.

[65]  O. Fiehn Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.

[66]  D. Hochstrasser,et al.  Industrial‐scale proteomics: From liters of plasma to chemically synthesized proteins , 2004, Proteomics.

[67]  S. L. Bridges Genetic markers of treatment response in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[68]  M. Glocker,et al.  Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. , 2004, Pathology, research and practice.

[69]  Marcel Dettling,et al.  BagBoosting for tumor classification with gene expression data , 2004, Bioinform..

[70]  R. Christopher,et al.  Data‐Driven Computer Simulation of Human Cancer Cell , 2004, Annals of the New York Academy of Sciences.

[71]  M. Glocker,et al.  High Detection Sensitivity Achieved with Cryogenic Detectors in Combination with Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry , 2004, European journal of mass spectrometry.

[72]  Reinhard Guthke,et al.  Dynamic network reconstruction from gene expression data applied to immune response during bacterial infection , 2005, Bioinform..